Especially on X, algorithmic culture is characterized by ceaseless iteration: Everything that’s happening is piled atop all ...

Here is the AI research roadmap for 2026: how agents that learn, self-correct, and simulate the real world will redefine ...

The K-star opens up on streaming, bold experiments and finding his way back to the stage. Read more at straitstimes.com. Read ...

2025 has come and gone. It was an interesting year and had its fair share of weird Vancouver stories. We’ve gone through some ...

Digital asset regulation finally shifted into gear in 2025 as the US moved toward a more crypto-friendly legal framework and ...

The Admiral Twin Drive-In in Tulsa stands as a magnificent time capsule where cinema magic meets starlit Oklahoma skies, creating an experience that will have you wondering why you waited so long to ...

The Admiral Twin Drive-In in Tulsa stands as a magnificent time capsule where cinema magic meets starlit Oklahoma skies, drawing movie lovers from Broken Arrow to Bartlesville and beyond. Remember ...

Between Choice and Fate at Batsford Gallery has a very charged yet subtle quality. The gallery’s atmosphere seems more akin ...

Eli Lilly is a well-established pharmaceutical company with a portfolio of products that consistently generate revenue and ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...